Back
ResMed Quote, Financials, Valuation and Earnings
Sponsored
RMD
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
RMD
ResMed
Last Price:
243.63
Seasonality Move:
9.06%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.ResMed Price Quote
$243.63
+2.08 (+0.86%)
(Updated: November 21, 2024 at 5:10 PM ET)
ResMed Key Stats
Sell
49
ResMed (RMD)
is a Sell
Day range:
$236.72 - $242.47
52-week range:
$148.03 - $260.49
Dividend yield:
0.84%
P/E ratio:
34.60
P/S ratio:
7.35
P/B ratio:
6.77%
Volume:
549.3K
Avg. volume:
1.1M
1-year change:
59.74%
Market cap:
$35.1B
Revenue:
$4.7B
EPS:
$7.55
How Much Does ResMed Make?
Is ResMed Growing As A Company?
ResMed Stock Price Performance
What Is ResMed 52-Week High & Low?
ResMed Price To Free Cash Flow
-
Is ResMed Stock Overvalued?
ResMed is trading at a price to free cash flow ratio of 26.23 -
Is ResMed Stock Undervalued?
ResMed EV to Free Cash Flow ratio is 26.28 -
What Is ResMed’s Price Earnings Growth Ratio?
RMD PEG ratio is 1.41 -
Is ResMed Trading At A Premium To Earnings?
ResMed EV to EBIT ratio is 25.13
Is It Risky To Buy ResMed?
Is ResMed Cash Flow Positive?
ResMed Return On Invested Capital
ResMed Earnings Date & Stock Price
-
What Is ResMed's Stock Price Today?
A single share of RMD can be purchased today for 241.55 -
What Is ResMed’s Stock Symbol?
ResMed trades on the nyse under the ticker symbol: RMD -
When Is ResMed’s Next Earnings Date?
The next quarterly earnings date for ResMed is scheduled on January 24, 2025 -
When Is RMD's next ex-dividend date?
ResMed's next ex-dividend date is November 7, 2024 -
How To Buy ResMed Stock?
You can buy ResMed shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ResMed Competitors
ResMed Dividend Yield
ResMed Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 41.61% | 7.69% |
Revenue: | 11.09% | 3.52% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 6 |
Sell Recommendations: | 1 |
Price Target: | 253.39 |
Upside from Last Price: | 4.9% |